Kato T, Stine OC, McMahon FJ, Crowe RR
It affects approximately 1 in 10 women
These insights suggest that interventions aimed at restoring gut microbiota balancethrough dietary modifications, probiotics, fecal microbiota transplantation, etc.may offer novel therapeutic strategies to alleviate the debilitating symptoms of this complex condition [1, 8]
New Formulations: Efforts are underway to create more convenient formulations, including longer-acting injectables that may only require monthly administration and improved oral versions
Manufacturer savings programs Both Novo Nordisk (maker of Wegovy and Ozempic) and Eli Lilly (maker of Zepbound and Mounjaro) offer savings programs that can reduce out-of-pocket costs for eligible patients
Background and aims: Knowledge about the actions of glucagon-like peptide-1 (GLP-1) in humans is increasing, however understanding of GLP-1 receptor (GLP-1R) expression and its relation with GLP-1 signaling remains incomplete